Literature DB >> 6198115

Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.

R G Titus, A Kelso, J A Louis.   

Abstract

Supernatants (SN) from cloned T cell lines, lymphokine secreting tumour cell lines and mixed lymphocyte culture were analysed for their ability to induce murine peritoneal exudate cell (PEC) macrophages (M phi) parasitized with Leishmania tropica to destroy the parasite. The ability of the SN to induce parasite destruction in parasitized PEC M phi correlated with their content of macrophage activating factor/interferon. Neither granulocyte-macrophage colony stimulating factor, M phi colony stimulating factor nor interleukin 2 was required for the induction of parasiticidal activity by infected PEC M phi. Similar results were also obtained using either a different Leishmania species, Leishmania enriettii, or a second source of cells: bone marrow derived macrophages.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6198115      PMCID: PMC1535781     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Interferon: an inducer of macrophage activation by polyanions.

Authors:  R M Schultz; J D Papamatheakis; M A Chirigos
Journal:  Science       Date:  1977-08-12       Impact factor: 47.728

Review 2.  The in vitro generation and functional analysis of murine T cell populations and clones specific for a protozoan parasite, Leishmania tropica.

Authors:  J A Louis; R H Zubler; S G Coutinho; G Lima; R Behin; J Mauel; H D Engers
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

3.  Production of macrophage activation factor by a T-cell hybridoma.

Authors:  T L Ratliff; D L Thomasson; R E McCool; W J Catalona
Journal:  Cell Immunol       Date:  1982-04       Impact factor: 4.868

4.  Direct toxic effects of immunopotentiators on monocytic, myelomonocytic, and histiocytic or macrophage tumor cells in culture.

Authors:  P Ralph; I Nakoinz
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

5.  Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. I. Lack of effects of immune lymphocytes and of activated macrophages.

Authors:  J Mauel; R Behin; D S Rowe
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

6.  Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.

Authors:  M S Meltzer; W R Benjamin; J J Farrar
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Colony-stimulating factors and regulation of macrophage tumoricidal and microbicidal activities.

Authors:  P Ralph; C A Nacy; M S Meltzer; N Williams; I Nakoinz; E J Leonard
Journal:  Cell Immunol       Date:  1983-02-15       Impact factor: 4.868

8.  Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages.

Authors:  C A Nacy; M S Meltzer; E J Leonard; D J Wyler
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

9.  Studies on the mechanisms of macrophage activation. I. Destruction of intracellular Leishmania enriettii in macrophages activated by cocultivation with stimulated lymphocytes.

Authors:  J Mauel; Y Buchmüller; R Behin
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

10.  Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures.

Authors:  J C Cerottini; H D Engers; H R Macdonald; T Brunner
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

View more
  26 in total

1.  Nucleosides from Phlebotomus papatasi salivary gland ameliorate murine collagen-induced arthritis by impairing dendritic cell functions.

Authors:  Vanessa Carregaro; Anderson Sá-Nunes; Thiago M Cunha; Renata Grespan; Carlo J F Oliveira; Djalma S Lima-Junior; Diego L Costa; Waldiceu A Verri; Cristiane M Milanezi; Van My Pham; David D Brand; Jesus G Valenzuela; João S Silva; José M C Ribeiro; Fernando Q Cunha
Journal:  J Immunol       Date:  2011-09-19       Impact factor: 5.422

2.  Priming of a beta-galactosidase (beta-GAL)-specific type 1 response in BALB/c mice infected with beta-GAL-transfected Leishmania major.

Authors:  H R Chakkalath; A A Siddiqui; A H Shankar; D E Dobson; S M Beverley; R G Titus
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Novel compounds active against Leishmania major.

Authors:  Stephanie St George; Jeanette V Bishop; Richard G Titus; Claude P Selitrennikoff
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection.

Authors:  Yasuyuki Goto; Ajay Bhatia; Vanitha S Raman; Silvia E Z Vidal; Sylvie Bertholet; Rhea N Coler; Randall F Howard; Steven G Reed
Journal:  Vaccine       Date:  2009-03-09       Impact factor: 3.641

5.  Nucleosides present on phlebotomine saliva induce immunossuppression and promote the infection establishment.

Authors:  Vanessa Carregaro; José M Ribeiro; Jesus G Valenzuela; Djalma L Souza-Júnior; Diego L Costa; Carlo J F Oliveira; Laís A Sacramento; Manuela S L Nascimento; Cristiane M Milanezi; Fernando Q Cunha; João S Silva
Journal:  PLoS Negl Trop Dis       Date:  2015-04-07

6.  Influence of costimulatory molecules on immune response to Leishmania major by human cells in vitro.

Authors:  C I Brodskyn; G K DeKrey; R G Titus
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

7.  Development of a safe live Leishmania vaccine line by gene replacement.

Authors:  R G Titus; F J Gueiros-Filho; L A de Freitas; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Expansion of gamma interferon-producing CD8+ T cells following secondary infection of mice immune to Leishmania major.

Authors:  I Müller; P Kropf; J A Louis; G Milon
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.

Authors:  June Ghosh; Shantanabha Das; Rajan Guha; Debopam Ghosh; Kshudiram Naskar; Anjan Das; Syamal Roy
Journal:  J Lipid Res       Date:  2012-10-10       Impact factor: 5.922

10.  Thymopentin reduces the susceptibility of aged mice to cutaneous leishmaniasis by modulating CD4 T-cell subsets.

Authors:  E Cillari; S Milano; M Dieli; F Arcoleo; R Perego; F Leoni; G Gromo; A Severn; F Y Liew
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.